Structures by: Nangia A.
Total: 676
2,4,6-tris(2-chloro-3-pyridyloxy)-1,3,5-triazine
C18H9Cl3N6O3
CrystEngComm (2006) 8, 6 440
a=17.2490(9)Å b=17.2490(9)Å c=12.0227(12)Å
α=90.00° β=90.00° γ=120.00°
2, 4, 6-tris(2-chloro-3-pyridinoxy)-1 ,3, 5-triazine, ethylmethylketone
C18H9N6O3Cl3,0.5(C4H8O)
CrystEngComm (2006) 8, 6 440
a=6.2589(5)Å b=10.1316(8)Å c=16.8663(13)Å
α=86.0240(10)° β=87.5270(10)° γ=88.2010(10)°
C12H18N2O3S
C12H18N2O3S
CrystEngComm (2011) 13, 1 47
a=15.851(6)Å b=9.288(4)Å c=19.691(8)Å
α=90.00° β=90.00° γ=90.00°
C12H18N2O3S
C12H18N2O3S
CrystEngComm (2011) 13, 1 47
a=11.5613(17)Å b=27.189(4)Å c=13.556(2)Å
α=90.00° β=102.803(2)° γ=90.00°
C12H18N2O3S
C12H18N2O3S
CrystEngComm (2011) 13, 1 47
a=11.787(5)Å b=9.043(4)Å c=13.955(6)Å
α=90.00° β=104.644(7)° γ=90.00°
(C24H20AgCl2N6O2),(C2H3N),(NO3)
(C24H20AgCl2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=9.3502(6)Å b=12.0861(8)Å c=13.0114(8)Å
α=85.5080(10)° β=80.5210(10)° γ=72.6230(10)°
(C24H20AgBr2N6O2),(C2H3N),(NO3)
(C24H20AgBr2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=9.5477(5)Å b=12.3303(6)Å c=12.8922(7)Å
α=84.5970(10)° β=79.3760(10)° γ=71.7090(10)°
(C24H20AgF2N6O2),(C2H3N),(NO3)
(C24H20AgF2N6O2),(C2H3N),(NO3)
CrystEngComm (2008) 10, 12 1891
a=10.3793(9)Å b=11.5395(10)Å c=12.4980(11)Å
α=95.3540(10)° β=101.5830(10)° γ=112.4090(10)°
(C48H40Ag2I4N12O4),2(C2H3N),2(NO3)
(C48H40Ag2I4N12O4),2(C2H3N),2(NO3)
CrystEngComm (2008) 10, 12 1891
a=13.2760(10)Å b=15.0546(12)Å c=17.5415(14)Å
α=107.8060(10)° β=105.0930(10)° γ=106.9840(10)°
2(C26H23Ag1F2N7O2),(C2H3N),2(NO3)
2(C26H23Ag1F2N7O2),(C2H3N),2(NO3)
CrystEngComm (2008) 10, 12 1891
a=16.6486(16)Å b=10.3266(10)Å c=32.967(3)Å
α=90.00° β=90.225(2)° γ=90.00°
(C26H25AgN7O2)(C24H22AgN6O2)2(NO3)
(C26H25AgN7O2)(C24H22AgN6O2)2(NO3)
CrystEngComm (2008) 10, 12 1891
a=19.4555(12)Å b=25.7212(16)Å c=10.2172(6)Å
α=90.00° β=102.6250(10)° γ=90.00°
0.5(C48H40Ag2Br2.18I1.82N12O4),C2H3N,NO3
0.5(C48H40Ag2Br2.18I1.82N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.7667(17)Å b=12.505(2)Å c=12.752(2)Å
α=83.684(3)° β=78.689(3)° γ=70.921(2)°
0.5(C48H40Ag2Br2.92I1.08N12O4),C2H3N,NO3
0.5(C48H40Ag2Br2.92I1.08N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.6987(7)Å b=12.4579(9)Å c=12.7686(9)Å
α=84.0100(10)° β=78.7800(10)° γ=71.0240(10)°
0.5(C48H40Ag2Br3.88I0.12N12O4),C2H3N,NO3
0.5(C48H40Ag2Br3.88I0.12N12O4),C2H3N,NO3
CrystEngComm (2008) 10, 12 1891
a=9.5811(9)Å b=12.3598(12)Å c=12.8807(13)Å
α=84.463(2)° β=79.304(2)° γ=71.599(2)°
Tetrakis-(4-sulfonatophenyl)methane
C50H32O44S8
CrystEngComm (2007) 9, 8 628
a=21.8492(12)Å b=21.8492(12)Å c=7.3635(9)Å
α=90.00° β=90.00° γ=90.00°
Cyclo(Phe-Pro-Leu-Aha)
C26H38N4O4,3(H2O)
CrystEngComm (2007) 9, 10 860
a=9.4493(16)Å b=14.125(2)Å c=21.736(4)Å
α=90.00° β=90.00° γ=90.00°
Pyrazine-N,N'-dioxide
C2H2NO,0.5(C4H4N2O2)
CrystEngComm (2007) 9, 11 980
a=11.8672(18)Å b=12.2217(19)Å c=6.4287(10)Å
α=90.00° β=90.00° γ=90.00°
Pyrazine-N,N'-dioxide
C4H4N2O2
CrystEngComm (2007) 9, 11 980
a=3.7239(13)Å b=11.010(4)Å c=5.683(2)Å
α=90.00° β=96.237(5)° γ=90.00°
C26H38N4O4
C26H38N4O4
CrystEngComm (2007) 9, 10 860
a=11.292(6)Å b=15.112(10)Å c=15.805(12)Å
α=90° β=90° γ=90°
C21H23N3O4
C21H23N3O4
CrystEngComm (2011) 13, 9 3232
a=8.930(3)Å b=9.877(3)Å c=22.497(6)Å
α=90.00° β=90.00° γ=90.00°
C20H24N3O2
C20H24N3O2
CrystEngComm (2011) 13, 9 3232
a=10.631(9)Å b=9.315(8)Å c=18.052(15)Å
α=90.00° β=103.771(13)° γ=90.00°
C21H25N3O5
C21H25N3O5
CrystEngComm (2011) 13, 9 3232
a=25.244(4)Å b=18.525(3)Å c=8.9052(13)Å
α=90.00° β=102.753(3)° γ=90.00°
C17H27Cl2N3O3
C17H27Cl2N3O3
CrystEngComm (2011) 13, 9 3232
a=8.539(3)Å b=13.703(4)Å c=17.468(5)Å
α=90.00° β=103.311(5)° γ=90.00°
C24H25N3O3
C24H25N3O3
CrystEngComm (2011) 13, 9 3232
a=13.941(8)Å b=15.599(9)Å c=9.412(5)Å
α=90.00° β=99.499(11)° γ=90.00°
C17H20N3O0.5
C17H20N3O0.5
CrystEngComm (2011) 13, 9 3232
a=9.801(3)Å b=17.308(5)Å c=9.009(2)Å
α=90.00° β=106.000(4)° γ=90.00°
C17H20N3O0.5
C17H20N3O0.5
CrystEngComm (2011) 13, 9 3232
a=9.801(3)Å b=17.308(5)Å c=9.009(2)Å
α=90.00° β=106.000(4)° γ=90.00°
C23H33ClFN3O
C23H33ClFN3O
CrystEngComm (2012) 14, 7 2367
a=17.0708(14)Å b=11.9644(10)Å c=11.0576(9)Å
α=90.00° β=106.1890(10)° γ=90.00°
C23H31ClFN3
C23H31ClFN3
CrystEngComm (2012) 14, 7 2367
a=7.485(10)Å b=8.578(9)Å c=16.794(18)Å
α=82.718(17)° β=85.478(17)° γ=84.883(11)°
C16H18N6O6
C16H18N6O6
CrystEngComm (2012) 14, 7 2579
a=7.883(2)Å b=8.697(3)Å c=12.506(4)Å
α=90.00° β=97.74(3)° γ=90.00°
C8H10N3O3
C8H10N3O3
CrystEngComm (2012) 14, 7 2579
a=6.971(6)Å b=19.508(17)Å c=7.260(6)Å
α=90.00° β=114.603(13)° γ=90.00°
C16H18N6O6
C16H18N6O6
CrystEngComm (2012) 14, 7 2579
a=8.1339(3)Å b=8.7424(4)Å c=12.4779(5)Å
α=90.00° β=96.933(4)° γ=90.00°
C7H8N3O3
C7H8N3O3
CrystEngComm (2012) 14, 7 2579
a=3.8701(4)Å b=17.3536(18)Å c=12.4978(13)Å
α=90.00° β=95.859(2)° γ=90.00°
Hydrate of 1:1 cocrystal of Temozolomide and Formic acid
2(C6H6N6O2),CH4O3
CrystEngComm (2013) 15, 4 666
a=8.173(12)Å b=11.626(17)Å c=11.735(17)Å
α=64.73(2)° β=74.09(3)° γ=89.31(3)°
C6H7N6O2,C6H6N6O2,2(Cl),H3O,3(H2O
C6H7N6O2,C6H6N6O2,2(Cl),H3O,3(H2O
CrystEngComm (2013) 15, 4 666
a=6.453(15)Å b=10.37(2)Å c=17.84(4)Å
α=97.80(4)° β=90.44(4)° γ=98.27(4)°
C21H18ClNO6
C21H18ClNO6
CrystEngComm (2013) 15, 1 34
a=11.858(3)Å b=4.8452(9)Å c=16.785(3)Å
α=90.00° β=102.47(2)° γ=90.00°
From D:/data/P.Sapui/gsas_26052012/ps1.cif
C21H18ClNO6
CrystEngComm (2013) 15, 1 34
a=22.5733(13)Å b=4.89448(21)Å c=18.3874(9)Å
α=90.0° β=108.5192(27)° γ=90.0°
Etoricoxib-adipic acid cocrystal
C18H15ClN2O2S,0.5(C6H10O4)
CrystEngComm (2016) 18, 16 2825
a=16.6417(18)Å b=5.4913(6)Å c=23.838(3)Å
α=90° β=98.603(2)° γ=90°
Etoricoxib-caprolactam dihydrate
2(C18H15ClN2O2S),C6H11NO,2(H2O)
CrystEngComm (2016) 18, 16 2825
a=12.552(3)Å b=12.574(3)Å c=14.989(3)Å
α=96.690(3)° β=114.553(2)° γ=90.099(3)°
Etoricoxib-gluraric acid cocrystal
C23H23ClN2O6S
CrystEngComm (2016) 18, 16 2825
a=11.8317(15)Å b=12.7266(16)Å c=15.772(2)Å
α=90° β=90.203(2)° γ=90°
Etoricoxib-suberic acid cocrystal
C18H15ClN2O2S,C8H14O4
CrystEngComm (2016) 18, 16 2825
a=9.0238(3)Å b=10.1284(5)Å c=14.8544(9)Å
α=82.766(5)° β=77.640(4)° γ=85.386(4)°
Sparfloxacin-methyl paraben cocrystal
C19H22F2N4O3,C8H8O3
Chemical communications (Cambridge, England) (2016) 52, 85 12610-12613
a=9.423(5)Å b=12.742(7)Å c=12.890(7)Å
α=62.717(9)° β=70.160(9)° γ=76.407(10)°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl)ethane - 1-bromo-1,2-bis(4-pyridyl)ethylene - 1,2-dibromo-1,2-bis(4-pyridyl)ethane
C9H12O6,0.82(C12H12N2),0.18(C12H9BrN2),0.5(C12H10Br2N2)
New Journal of Chemistry (2008) 32, 5 800
a=11.328(3)Å b=11.837(3)Å c=20.015(5)Å
α=90.00° β=94.448(4)° γ=90.00°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl)ethane - 1,4-bis(4-pyridyl)butane - o-xylene
(C14H16N2),2(C9H12O6),2(C12H12N2),(C8H10)
New Journal of Chemistry (2008) 32, 5 800
a=5.7049(6)Å b=14.0883(16)Å c=18.287(2)Å
α=85.834(2)° β=82.960(2)° γ=82.027(2)°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl)ethane - 1,4-bis(4-pyridyl)butane - o-dichlorobenzene
(C9H12O6),(C12H12N2),0.5(C14H16N2),0.5(C6H4Cl2)
New Journal of Chemistry (2008) 32, 5 800
a=5.6867(3)Å b=14.0676(8)Å c=18.3545(10)Å
α=88.4000(10)° β=86.0400(10)° γ=81.1640(10)°
Cis,cis-1,3,5-cyclohexanetricarboxylic acid - 1,2-bis(4-pyridyl)ethane - 1,4-bis(4-pyridyl)butane - anisole
2(C9H12O6),(C14H16N2),2(C12H12N2),(C7H8O)
New Journal of Chemistry (2008) 32, 5 800
a=5.7484(5)Å b=14.1360(12)Å c=18.1188(15)Å
α=85.7580(10)° β=83.8170(10)° γ=81.5740(10)°
1,4-di(bis(3'-hydroxy,2'-,4'-dimethoxyphenyl)methyl)benzene dimethylsulfoxide solvate
C40H42O12,2(C2H6OS)
New Journal of Chemistry (2010) 34, 4 623
a=10.8550(7)Å b=14.2040(9)Å c=14.8984(9)Å
α=90.00° β=111.1700(10)° γ=90.00°
ABZ-BSA
C12H16N3O2S,C6H5O3S
CrystEngComm (2018) 20, 41 6394
a=8.5042(7)Å b=9.4678(7)Å c=26.084(2)Å
α=96.005(6)° β=93.966(7)° γ=102.377(7)°
Indapamide-methylpyridone cocrystal
C16H16ClN3O3S,C6H7NO
CrystEngComm (2019) 21, 13 2043
a=7.765(7)Å b=8.741(8)Å c=34.52(3)Å
α=90° β=93.96(4)° γ=90°
Epalrestat
C15H13NO3S2
Chemical communications (Cambridge, England) (2016) 52, 21 4037-4040
a=14.7831(13)Å b=5.6288(5)Å c=18.2621(16)Å
α=90° β=98.364(8)° γ=90°
2,4,6-Tris-(4-nitrophenoxy)-1,3,5-triazine, Benzene solvate
C48H30N12O18
Chemical Communications (2002) 9 952
a=14.195(2)Å b=14.195(2)Å c=20.941(5)Å
α=90.00° β=90.00° γ=120.00°
1:1 molecular complex of 4-hydroxybenzoic acid and isonicotinamide
C7H6O3,C6H6N2O
CrystEngComm (2003) 5, 31 164
a=6.0729(1)Å b=9.4013(2)Å c=20.6723(4)Å
α=90.00° β=95.2870(10)° γ=90.00°
C20H23N3O4
C20H23N3O4
CrystEngComm (2011) 13, 9 3232
a=10.3222(16)Å b=10.7865(17)Å c=10.8589(17)Å
α=111.053(2)° β=115.931(2)° γ=99.711(2)°
C7H7N3O3
C7H7N3O3
CrystEngComm (2012) 14, 7 2579
a=3.7408(7)Å b=17.352(2)Å c=12.558(2)Å
α=90.00° β=95.760(16)° γ=90.00°
Etoricoxib-suberic acid cocrystal hydrate
2(C18H15ClN2O2S),0.5(C8H14O4),2(H2O),O
CrystEngComm (2016) 18, 16 2825
a=12.2796(15)Å b=12.4817(10)Å c=14.8713(18)Å
α=95.187(8)° β=113.754(12)° γ=91.242(8)°
Glibenclamide
C23H28ClN3O5S
CrystEngComm (2017) 19, 6 918
a=9.45444(13)Å b=17.6795(3)Å c=14.4839(2)Å
α=90° β=93.4373(13)° γ=90°
Glibenclamide-sodiumhydrate salt
C23H27ClN3NaO6S
CrystEngComm (2017) 19, 6 918
a=19.5991(16)Å b=5.8086(3)Å c=23.4722(17)Å
α=90° β=108.746(8)° γ=90°
Glibenclamide-ammonium salt
C23H31ClN4O5S
CrystEngComm (2017) 19, 6 918
a=19.718(4)Å b=6.1475(11)Å c=21.732(5)Å
α=90° β=109.25(2)° γ=90°
Glibenclamide-potassium salt
C23H27ClKN3O5S
CrystEngComm (2017) 19, 6 918
a=19.819(4)Å b=6.2006(9)Å c=21.636(5)Å
α=90° β=109.69(2)° γ=90°
Glibenclamidesodium salt
C23H27ClN3NaO5S
CrystEngComm (2017) 19, 6 918
a=19.7594(13)Å b=6.1759(3)Å c=21.5560(15)Å
α=90° β=109.627(7)° γ=90°
Dibromophloroglucinol, tetrahydrate
C6H4Br2O3,4(H2O)
Chemical Communications (2006)
a=16.0309(12)Å b=10.6848(8)Å c=7.3246(5)Å
α=90.00° β=111.4500(10)° γ=90.00°
Dibromophloroglucinol, tetrahydrate
C6H4Br2O3,4(H2O)
Chemical Communications (2006)
a=16.135(4)Å b=10.740(2)Å c=7.4390(17)Å
α=90.00° β=111.354(3)° γ=90.00°
Dibromophloroglucinol
C6H4Br2O3
Chemical Communications (2006)
a=5.4011(5)Å b=12.8974(13)Å c=10.9478(11)Å
α=90.00° β=90.00° γ=90.00°
C21H20O6
C21H20O6
Chem.Commun. (2011) 47, 5013
a=12.5676(11)Å b=7.0425(6)Å c=19.9582(18)Å
α=90.00° β=94.9870(10)° γ=90.00°
C21H20O6
C21H20O6
Chem.Commun. (2011) 47, 5013
a=12.536(3)Å b=7.9916(17)Å c=34.462(7)Å
α=90.00° β=90.00° γ=90.00°
C21H20O6
C21H20O6
Chem.Commun. (2011) 47, 5013
a=35.417(3)Å b=7.7792(7)Å c=12.6482(11)Å
α=90.00° β=90.00° γ=90.00°
C22H22O2
C22H22O2
Chemical Communications (2005)
a=20.8580(12)Å b=20.8580(12)Å c=10.0116(12)Å
α=90.00° β=90.00° γ=120.00°
C22H22O2
C22H22O2
Chemical Communications (2005)
a=9.553(2)Å b=4.5252(11)Å c=20.210(5)Å
α=90.00° β=100.555(3)° γ=90.00°
C18H14O2,C2H6OS
C18H14O2,C2H6OS
Chemical Communications (2005)
a=7.1305(14)Å b=34.505(7)Å c=6.8846(14)Å
α=90.00° β=90.00° γ=90.00°
1,1-Bis(4-Hydroxypheyl)cyclohexane
C18H20O2
Chemical Communications (2006) 47
a=6.2275(6)Å b=10.8480(10)Å c=11.3359(11)Å
α=101.611(2)° β=103.4240(10)° γ=103.117(2)°
1,1-bis(4-Hydroxyphenyl)cyclohexane
C18H20O2
Chemical Communications (2006) 47
a=9.6278(5)Å b=20.9561(11)Å c=28.0324(14)Å
α=90.00° β=90.00° γ=90.00°
N-4-bromophenyl-N'-4'-nitrophenylurea
C13H10BrN3O3
Chemical communications (Cambridge, England) (2004) 10 1202-1203
a=7.9974(8)Å b=13.4826(13)Å c=12.0227(12)Å
α=90.00° β=94.671(2)° γ=90.00°
N-4-chlorophenyl-N'-4'-nitrophenylurea
C13H10ClN3O3
Chemical communications (Cambridge, England) (2004) 10 1202-1203
a=8.0360(5)Å b=13.3397(8)Å c=11.8513(7)Å
α=90.00° β=94.8820(10)° γ=90.00°
N-4-ethynyl-N'-4'-nitrophenylurea
C15H11N3O3
Chemical communications (Cambridge, England) (2004) 10 1202-1203
a=13.422(3)Å b=4.6511(9)Å c=21.261(4)Å
α=90.00° β=94.97(3)° γ=90.00°
N-4-iodophenyl-N'-4'-nitrophenylurea
C13H10IN3O3
Chemical communications (Cambridge, England) (2004) 10 1202-1203
a=13.552(3)Å b=4.6722(9)Å c=21.377(6)Å
α=90.00° β=90.40(3)° γ=90.00°
Hydrate of 1:1 complex of barbituric acid and bipyridine-bis- N-oxide
C10H8N2O2,C4H4N2O3,H2O
Chemical Communications (2006)
a=16.2210(11)Å b=6.5971(5)Å c=27.0692(19)Å
α=90.00° β=90.00° γ=90.00°
Isonicotinamide-N-oxide
C6H6N2O2
Chemical Communications (2006)
a=13.467(3)Å b=11.722(3)Å c=3.7370(10)Å
α=90.00° β=90.00° γ=90.00°
Nicotinamide-N-oxide
C6H6N2O2
Chemical Communications (2006)
a=11.0498(16)Å b=3.6869(5)Å c=15.019(2)Å
α=90.00° β=110.064(2)° γ=90.00°
Pyridine-2-carboxamide-N-oxide
C6H6N2O2
Chemical Communications (2006)
a=12.940(3)Å b=7.3496(19)Å c=13.087(3)Å
α=90.00° β=90.00° γ=90.00°
Pyrazinamide-4-N-oxide
C5H5N3O2
Chemical Communications (2006)
a=5.403(3)Å b=7.508(4)Å c=14.978(8)Å
α=96.838(9)° β=97.094(9)° γ=102.822(9)°
1:0.5 complex of phenobarbital and bipyridine-bis-N-oxide
C12H12N2O3,0.5(C10H8N2O2)
Chemical Communications (2006)
a=10.3768(12)Å b=15.8728(18)Å c=9.4522(11)Å
α=90.00° β=93.165(2)° γ=90.00°
4,4-bis(4-hydroxyphenyl)cyclohexanone
C18H18O3
CrystEngComm (2003) 5, 78 447
a=14.391(3)Å b=20.228(4)Å c=9.782(2)Å
α=90.00° β=91.96(3)° γ=90.00°
4,4-bis(3-methyl-4-hydroxyphenyl)cyclohexanone
C20H22O3
CrystEngComm (2003) 5, 78 447
a=10.004(2)Å b=15.783(3)Å c=20.253(4)Å
α=90.00° β=94.79(3)° γ=90.00°
4-(triphenylmethyl)benzoic acid p-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.241(2)Å b=9.011(2)Å c=18.916(3)Å
α=84.25(2)° β=87.25(2)° γ=66.66(2)°
4-(triphenylmethyl)benzoic acid mesitylene clathrate
(C26H20O2).(C9H12)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.390(1)Å b=13.637(1)Å c=14.349(1)Å
α=75.92(1)° β=81.64(1)° γ=85.16(1)°
4-(triphenylmethyl)benzoic acid xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3270(10)Å b=9.042(2)Å c=18.534(4)Å
α=88.09(3)° β=85.07(3)° γ=68.07(3)°
4-(triphenylmethyl)benzoic acid chlorobenzene clathrate
(C26H20O2).0.5(C6H5Cl)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3100(10)Å b=8.9940(10)Å c=18.454(2)Å
α=89.190(10)° β=85.750(10)° γ=68.230(10)°
4-(triphenylmethyl)benzoic acid m-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.329(1)Å b=9.044(1)Å c=18.547(1)Å
α=88.54(1)° β=85.33(1)° γ=67.63(1)°
4-(triphenylmethyl)benzoic acid o-xylene clathrate
(C26H20O2).0.5(C8H10)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.368(1)Å b=9.010(1)Å c=18.522(1)Å
α=88.00(1)° β=84.97(1)° γ=67.94(1)°
4-(triphenylmethyl)benzoic acid bromobenzene clathrate
(C26H20O2).0.5(C6H5Br)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.3066(2)Å b=8.9943(2)Å c=18.4963(5)Å
α=89.764(1)° β=85.946(1)° γ=67.868(1)°
4-(triphenylmethyl)benzoic acid nitrobenzene clathrate
(C26H20O2).0.5(C6H5NO2)
Journal of the Chemical Society, Perkin Transactions 2 (2000) 6 1223
a=7.340(2)Å b=8.982(2)Å c=18.366(4)Å
α=89.33(3)° β=86.14(3)° γ=67.55(3)°
Sulfacetamide-acetamide
C8H10N2O3S.C2H5NO
CrystEngComm (2013) 15, 37 7456
a=11.2134(6)Å b=7.7976(4)Å c=16.1280(7)Å
α=90.00° β=103.260(5)° γ=90.00°
Sulfacetamide-acetamide
C8H10N2O3S.C2H5NO
CrystEngComm (2013) 15, 37 7456
a=22.2392(16)Å b=8.4705(4)Å c=14.7710(11)Å
α=90.00° β=107.056(8)° γ=90.00°
NAC
C5H9NO3S
CrystEngComm (2013) 15, 33 6498
a=5.1041(7)Å b=5.9092(8)Å c=6.5261(10)Å
α=96.484(12)° β=103.696(13)° γ=101.969(11)°
NAC
C5H9NO3S
CrystEngComm (2013) 15, 33 6498
a=6.0684(6)Å b=7.6372(9)Å c=16.005(2)Å
α=90.00° β=90.00° γ=90.00°
Celecoxib-2-Pyrrolidinone
C17H14F3N3O2S,C4H7NO
CrystEngComm (2014) 16, 1 24
a=11.0368(5)Å b=8.6083(4)Å c=12.0762(6)Å
α=90.00° β=109.049(5)° γ=90.00°
Celecoxib-Aza-2-cyclooctanone
C17H14F3N3O2S,C7H13NO
CrystEngComm (2014) 16, 1 24
a=8.0409(5)Å b=27.2426(18)Å c=11.7927(8)Å
α=90.00° β=105.806(7)° γ=90.00°
Celecoxib-Caprolactam
C17H14F3N3O2S,C6H11NO
CrystEngComm (2014) 16, 1 24
a=11.7189(11)Å b=8.7409(6)Å c=12.0503(10)Å
α=90.00° β=103.353(10)° γ=90.00°
Celecoxib-Valerolactam-Form-I
C17H14F3N3O2S,C5H9NO
CrystEngComm (2014) 16, 1 24
a=8.7346(6)Å b=11.2689(10)Å c=12.2391(9)Å
α=81.622(7)° β=87.560(6)° γ=73.363(7)°
Celecoxib-Valerolactam-Form-II
C17H14F3N3O2S,C5H9NO
CrystEngComm (2014) 16, 1 24
a=22.591(2)Å b=8.6211(8)Å c=23.814(2)Å
α=90.00° β=102.1630(10)° γ=90.00°
Celecoxib-Valerolactam-Form-III
C17H14F3N3O2S,C6H11NO
CrystEngComm (2014) 16, 1 24
a=14.8501(18)Å b=8.4190(11)Å c=17.761(2)Å
α=90.00° β=93.901(2)° γ=90.00°